NEW YORK (
CHANGE IN RATINGS
upgraded at UBS to Buy from Neutral, UBS said. $39 price target. Reassessing risk/reward.
rated new Outperform at JMP. $118 price target. Upcoming Gore settlement should be a near-term catalyst.
The Chubb Corporation
downgraded at Morgan Stanley to Equal-weight from Overweight, Morgan Stanley said. Low yields constrain investment income growth.
(DNKN - Get Report)
upgraded at Miller Tabak from Hold to Buy, Miller Tabak said. $38 price target. Company should see higher sales in the coming quarters.
rated new Buy at Wunderlich. $56 price target. Permian basin should drive near-term growth.
Goodyear Tire & Rubber
upgraded to Buy at TheStreet Ratings.
rated new Buy at MKM. $28 price target. Company is on the path toward higher returns.
(HRB - Get Report)
downgraded at Compass Point from Buy to Neutral, Compass Point said. Valuation call, based on a $19.50 price target.
upgraded to buy at TheStreet Ratings.
rated new Overweight at JP Morgan. $62 price target. Company can expand margins and generate double-digit earnings growth.
rated new Neutral at UBS. $59 price target. Xtandi should drive conversion to profitability, but peak expectations high.
rated new Buy at UBS. $97 price target. Well positioned in oncology.
downgraded at Canaccord Genuity to Hold from Buy, Canaccord Genuity said. $34 price target. Utica prospect severely overbought.
rated new Buy at UBS. $32 price target. A healthy pipeline of opportunities.
(TGT - Get Report)
rated new Hold at Stifel. New initiatives may take time to grab hold.
upgraded at Craig Hallum to Buy from Hold, Craig Hallum said. $54 price target. Estimate cuts in the near term have subsided.
STOCK COMMENTS / EPS CHANGES
(BA - Get Report)
added to Priority Stock List at Wells. Company can return significant capital to shareholders over the next few years.
numbers cut at Guggenheim. Shares of BHI now seen reaching $48, according to Guggenheim. Estimates also reduced, given the company's new guidance. Neutral rating.
(ORCL - Get Report)
numbers raised at Jefferies. Shares of ORCL now seen reaching $35, Jefferies said. Estimates also raised on quarter beat. Hold rating.